Live cell imaging microscopes market to reach $2.5 billion by 2030 at 7.9% CAGR, driven by growing demand for cell-based research.
Read MoreMid-size pharmaceuticals market to reach $1059.05 billion by 2030 at 7.0% CAGR, driven by increased prevalence of chronic diseases.
Read MoreLive attenuated vaccines market to reach $41.11 billion by 2030 at 9.6% CAGR, driven by increasing prevalence of infectious diseases.
Read MoreMicrotubule inhibitor chemotherapy drugs market to reach $7.23 billion by 2030 at 5.8% CAGR, driven by increasing prevalence of cancer.
Read MoreThe global liraglutide market to reach $10.23 billion by 2030 at 8.3% CAGR, driven by increasing diabetic population.
Read MoreLipid regulators market to reach $10.38 billion by 2030 at 5.9% CAGR, driven by increasing prevalence of cardiovascular diseases.
Read MoreMicrocarrier beads market to reach $4.95 billion by 2030 at 8.9% CAGR, driven by growing trend of personalized medicine.
Read MoreLifestyle-related disease supplements market to reach $91.73 billion by 2030 at 9.5% CAGR, driven by rising awareness of health and wellness.
Read MoreLichen nitidus treatment market to reach $2.91 billion by 2030 at 7.4% CAGR, driven by significant growth in chemical exposure and rising prevalence of skin infections.
Read MoreLevofloxacin market to reach $2.42 billion by 2030 at 5.9% CAGR, driven by rising number of bacterial infections and increasing healthcare expenditure.
Read More